Image

Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking

Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to characterize an electroencephalogram (EEG) biomarker for fentanyl and understand where this signal is coming from in the brain. The investigators also aim to understand how this EEG biomarker is connected to patient perception to drug liking.

Eligibility

Inclusion Criteria:

  1. 18 years old or above (male and female)
  2. American Society of Anesthesiologists (ASA) physical status classification of I, II or III
  3. Candidates scheduled for general surgical procedures under general anesthesia and receive fentanyl for surgery

Exclusion Criteria:

  1. Craniofacial abnormalities
  2. Known or suspected difficult intubation or mask ventilation
  3. Known or suspected need for rapid sequence induction and intubation
  4. Body mass index above 45 kg/m2
  5. Allergies to fentanyl
  6. History of obstructive sleep apnea requiring CPAP
  7. History of obstructive or restrictive lung disease
  8. Opiate use within 24 hours
  9. History of opiate abuse within the last 3 years
  10. Known or suspected severe chronic pain condition that require use of opiates or limit daily activities
  11. MRI contraindications, such as presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments, or foreign objects in the eyes, skin, or body

Study details
    Brain Activity Related to Opioid Administration
    Brain Activity Related to Drug Liking

NCT06699953

Stanford University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.